Agile Therapeutics(AGRX) - 2019 Q4 - Annual Report

Use these links to rapidly review the document Table of Contents Item 8. Financial Statements and Supplementary Data Title of each class Trading Symbol(s) Name of exchange on which registered: Common stock, par value $0.0001 per share AGRX The Nasdaq Capital Market Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2019 OR o TRANSITION REPORT ...